speb/financial-data huggingface dataset:
CURI income_statement (quarterly, 2025-12-31) — Other Income Expense: 51000.00
CURI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 31000000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 31000000.00
CURI cash_flow (annual, 2025-12-31) — Other Non Cash Items: -13396000.00
CURI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -6377000.00
CURI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 461000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 461000.00
CURI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 470000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 470000.00
CURI balance_sheet (annual, 2025-12-31) — Other Properties: 3705000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Properties: 3705000.00
CURI balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 8966000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 8966000.00
CURI balance_sheet (annual, 2025-12-31) — Payables: 10792000.00
CURI balance_sheet (quarterly, 2025-12-31) — Payables: 10792000.00
CURI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 20054000.00
CURI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 20054000.00
CURI income_statement (annual, 2025-12-31) — Pretax Income: -6413000.00
CURI income_statement (quarterly, 2025-12-31) — Pretax Income: -3478000.00
CURI balance_sheet (annual, 2025-12-31) — Properties: 0.00
CURI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CURI cash_flow (annual, 2025-12-31) — Purchase Of Investment: -12301000.00
CURI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -494000.00
CURI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -102000.00
CURI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -25000.00
CURI balance_sheet (annual, 2025-12-31) — Receivables: 8893000.00
CURI balance_sheet (quarterly, 2025-12-31) — Receivables: 8893000.00
CURI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 31113000.00
CURI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7581000.00
CURI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14675000.00
CURI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3857000.00
CURI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CURI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CURI balance_sheet (annual, 2025-12-31) — Restricted Cash: 60000.00
CURI balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 60000.00
CURI balance_sheet (annual, 2025-12-31) — Retained Earnings: -335844000.00
CURI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -335844000.00
CURI cash_flow (annual, 2025-12-31) — Sale Of Investment: 35551000.00
CURI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 6751000.00
CURI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 14028000.00
CURI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 4377000.00
CURI income_statement (annual, 2025-12-31) — Selling General And Administration: 47849000.00
CURI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 14988000.00
CURI balance_sheet (annual, 2025-12-31) — Share Issued: 58950000.00
CURI balance_sheet (quarterly, 2025-12-31) — Share Issued: 58950000.00
CURI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14366000.00
CURI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4312000.00
CURI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 41487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 41487000.00
CURI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 10487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 10487000.00
CURI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 18480.00
CURI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CURI income_statement (annual, 2025-12-31) — Tax Provision: 14000.00
CURI income_statement (quarterly, 2025-12-31) — Tax Provision: 308000.00
CURI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CURI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CURI balance_sheet (annual, 2025-12-31) — Total Assets: 75731000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Assets: 75731000.00
CURI balance_sheet (annual, 2025-12-31) — Total Capitalization: 41487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 41487000.00
CURI balance_sheet (annual, 2025-12-31) — Total Debt: 3888000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Debt: 3888000.00
CURI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 41487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 41487000.00
CURI income_statement (annual, 2025-12-31) — Total Expenses: 78962000.00
CURI income_statement (quarterly, 2025-12-31) — Total Expenses: 22569000.00
CURI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 34244000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 34244000.00
CURI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 38296000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 38296000.00
CURI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3930000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3930000.00
CURI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -7304000.00
CURI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -3372000.00
CURI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 935000.00
CURI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 935000.00
CURI income_statement (annual, 2025-12-31) — Total Unusual Items: 88000.00
CURI income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CURI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 88000.00
CURI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CURI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 215890.00
CURI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 215890.00
CURI balance_sheet (annual, 2025-12-31) — Treasury Stock: 251000.00
CURI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 251000.00
CURI balance_sheet (annual, 2025-12-31) — Working Capital: 7121000.00
CURI balance_sheet (quarterly, 2025-12-31) — Working Capital: 7121000.00
CURI income_statement (quarterly, 2026-03-31) — +Operating Expense: 10048000.00
CURI income_statement (quarterly, 2026-03-31) — +Total Revenue: 15161000.00
CURI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6415000.00
CURI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5809000.00
CURI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 379136000.00
CURI cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 3678000.00
CURI cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 3678000.00
CURI cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -32000.00
CURI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 58949000.00
CURI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.02
CURI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 18378000.00
CURI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3783000.00
CURI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 5000.00
CURI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16900000.00
CURI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 20393000.00
CURI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -4862000.00
CURI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5174000.00
CURI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 2546000.00
CURI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1210000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -3081000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 583000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -227000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 202000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Payable: -3081000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2498000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3084000.00
CURI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 561000.00
CURI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3084000.00
CURI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1418000.00
CURI balance_sheet (quarterly, 2026-03-31) — Common Stock: 5000.00
CURI cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -4862000.00
CURI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 36461000.00
CURI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -311000.00
CURI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 6657000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 10653000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Assets: 27469000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 436000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 436000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 8618000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 8618000.00
CURI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 28794000.00
CURI cash_flow (quarterly, 2026-03-31) — Depreciation: 41000.00
CURI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3719000.00
CURI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3719000.00
CURI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 58949000.00
CURI income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.02
CURI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1328000.00
CURI balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 493000.00
CURI income_statement (quarterly, 2026-03-31) — EBIT: -1544000.00
CURI income_statement (quarterly, 2026-03-31) — EBITDA: 2175000.00
CURI income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 30000.00
CURI cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -30000.00
CURI cash_flow (quarterly, 2026-03-31) — End Cash Position: 16960000.00
CURI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5174000.00
CURI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1210000.00
CURI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6533000.00
CURI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 31311000.00
CURI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3055000.00
CURI income_statement (quarterly, 2026-03-31) — Gross Profit: 8504000.00
CURI balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 2959000.00
CURI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 61000.00
CURI income_statement (quarterly, 2026-03-31) — Interest Income: 210000.00
CURI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 210000.00
CURI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 36461000.00
CURI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 2546000.00
CURI balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2959000.00
CURI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 6657000.00
CURI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3347000.00
CURI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3347000.00
CURI balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 3698000.00
CURI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -311000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1328000.00
CURI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1328000.00
CURI income_statement (quarterly, 2026-03-31) — Net Interest Income: 210000.00
CURI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 2546000.00
CURI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 210000.00
CURI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1000.00
CURI balance_sheet (quarterly, 2026-03-31) — Net PPE: 3055000.00
CURI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
CURI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5150000.00
CURI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2175000.00
CURI income_statement (quarterly, 2026-03-31) — Normalized Income: -1328000.00
CURI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1210000.00
CURI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -30000.00
CURI income_statement (quarterly, 2026-03-31) — Operating Income: -1544000.00
CURI income_statement (quarterly, 2026-03-31) — Operating Revenue: 14843000.00
CURI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 59287000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1207000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1294000.00
CURI income_statement (quarterly, 2026-03-31) — Other Gand A: 1403000.00
CURI income_statement (quarterly, 2026-03-31) — Other Income Expense: 30000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 31311000.00
CURI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -3921000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 664000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 554000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Properties: 3055000.00
CURI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3493000.00
CURI balance_sheet (quarterly, 2026-03-31) — Payables: 7793000.00
CURI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 18446000.00
CURI income_statement (quarterly, 2026-03-31) — Pretax Income: -1304000.00
CURI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -2954000.00
CURI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
CURI balance_sheet (quarterly, 2026-03-31) — Receivables: 5809000.00
CURI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 6657000.00
CURI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3719000.00
CURI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -311000.00
CURI balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 60000.00
CURI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -342118000.00
CURI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5130000.00
CURI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 5500000.00
CURI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3515000.00
CURI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 10048000.00
CURI balance_sheet (quarterly, 2026-03-31) — Share Issued: 59593000.00
CURI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2241000.00
CURI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 36461000.00
CURI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5150000.00
CURI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CURI income_statement (quarterly, 2026-03-31) — Tax Provision: 24000.00
CURI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CURI balance_sheet (quarterly, 2026-03-31) — Total Assets: 69156000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 36461000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Debt: 3783000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 36461000.00
CURI income_statement (quarterly, 2026-03-31) — Total Expenses: 16705000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 32695000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 41687000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3901000.00
CURI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1544000.00
CURI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 885000.00
CURI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 306000.00
CURI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 562000.00
CURI balance_sheet (quarterly, 2026-03-31) — Working Capital: -1325000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 220000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Gross PPE: 0.00
CURN.SW cash_flow (annual, 2021-12-31) — Interest Paid Cfo: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Long Term Debt: 429000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 429000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
CURN.SW income_statement (annual, 2021-12-31) — Minority Interests: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Net Debt: 305000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Net PPE: 0.00
CURN.SW cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 0.00
CURN.SW income_statement (annual, 2021-12-31) — Other Special Charges: -280000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Prepaid Assets: 10000.00
CURN.SW cash_flow (annual, 2021-12-31) — Purchase Of PPE: 0.00
CURN.SW balance_sheet (annual, 2021-12-31) — Taxes Receivable: 2000.00
CURN.SW balance_sheet (annual, 2021-12-31) — Total Debt: 429000.00
CURN.SW income_statement (annual, 2021-12-31) — Total Other Finance Cost: 4000.00
CURN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 1840000.00
CURN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
CURN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 152000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 32478000.00
CURN.SW income_statement (annual, 2022-12-31) — Amortization: 1519000.00
CURN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1519000.00
CURN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 156719.00
CURN.SW income_statement (annual, 2022-12-31) — Basic EPS: -221.63
CURN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 124000.00
CURN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -4000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 11436000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1342000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1342000.00
CURN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -149000.00
CURN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -828000.00
CURN.SW cash_flow (annual, 2022-12-31) — Change In Payable: -15000.00
CURN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -992000.00
CURN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: 1218000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 11436000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6753000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 1636000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 1847000.00
CURN.SW cash_flow (annual, 2022-12-31) — Deferred Tax: -5156000.00
CURN.SW cash_flow (annual, 2022-12-31) — Depreciation: 3000.00
CURN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1522000.00
CURN.SW income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1522000.00
CURN.SW income_statement (annual, 2022-12-31) — Depreciation Income Statement: 3000.00
CURN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 156719.00
CURN.SW income_statement (annual, 2022-12-31) — Diluted EPS: -221.63
CURN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -34732000.00
CURN.SW income_statement (annual, 2022-12-31) — EBIT: -39893000.00
CURN.SW income_statement (annual, 2022-12-31) — EBITDA: -38371000.00
CURN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 1342000.00
CURN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: 392000.00
CURN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: -4657000.00
CURN.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CURN.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 1182000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 12400000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 13000.00
CURN.SW income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 38177000.00
CURN.SW income_statement (annual, 2022-12-31) — Interest Expense: 6000.00
CURN.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6000.00
CURN.SW cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -7000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 9753000.00
CURN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: 5479000.00
CURN.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 479000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 3000000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3000000.00
CURN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 479000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 13000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
CURN.SW income_statement (annual, 2022-12-31) — Minority Interests: 11000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 5483000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Net Debt: 1658000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 3000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income: -34732000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -34732000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -34743000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -34732000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -34732000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -34743000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -34743000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -10000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 479000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 479000.00
CURN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -10000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 1000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 10000.00
CURN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -5647000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 1064000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1382000.00
CURN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: -325000.00
CURN.SW income_statement (annual, 2022-12-31) — Normalized Income: -1602543.67
CURN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: -4653000.00
CURN.SW income_statement (annual, 2022-12-31) — Operating Income: -1840000.00
CURN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CURN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 252912.00
CURN.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 29000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 12400000.00
CURN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3326000.00
CURN.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 449000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 37000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 136000.00
CURN.SW income_statement (annual, 2022-12-31) — Other Special Charges: -131000.00
CURN.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CURN.SW balance_sheet (annual, 2022-12-31) — Payables: 189000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 22000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 65000.00
CURN.SW income_statement (annual, 2022-12-31) — Pretax Income: -39899000.00
CURN.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CURN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4000.00
CURN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1522000.00
CURN.SW income_statement (annual, 2022-12-31) — Research And Development: 1507000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: -37160000.00
CURN.SW cash_flow (annual, 2022-12-31) — Sale Of Business: 5483000.00
CURN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 1182000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 255268.00
CURN.SW income_statement (annual, 2022-12-31) — Special Income Charges: -38046000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 6753000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: -5647000.00
CURN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -4916543.67
CURN.SW income_statement (annual, 2022-12-31) — Tax Provision: -5156000.00
CURN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.13
CURN.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 93000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 14046000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 9753000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 3000000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 6753000.00
CURN.SW income_statement (annual, 2022-12-31) — Total Expenses: 1840000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 7293000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 12410000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5446000.00
CURN.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4000.00
CURN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: -38046000.00
CURN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -38046000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2356.00
CURN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 1000.00
CURN.SW balance_sheet (annual, 2022-12-31) — Working Capital: -211000.00
CURN.SW income_statement (annual, 2022-12-31) — Write Off: 0.00
CURN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 3535000.00
CURN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 41000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -13000.00
CURN.SW income_statement (annual, 2023-12-31) — Amortization: 479000.00
CURN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 11921000.00
CURN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 279976.00
CURN.SW income_statement (annual, 2023-12-31) — Basic EPS: -176.38
CURN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1342000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 13102000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 9000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Cash Financial: 9000.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 956000.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Payable: -97000.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 284000.00
CURN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: 1143000.00
CURN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: -1333000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 13102000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: -312000.00
CURN.SW cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 120000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 299000.00
CURN.SW cash_flow (annual, 2023-12-31) — Deferred Tax: -1382000.00
CURN.SW cash_flow (annual, 2023-12-31) — Depreciation: 489000.00
CURN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 12410000.00
CURN.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 489000.00
CURN.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 10000.00
CURN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 279976.00
CURN.SW income_statement (annual, 2023-12-31) — Diluted EPS: -176.38
CURN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — EBIT: -50745000.00
CURN.SW income_statement (annual, 2023-12-31) — EBITDA: -38335000.00
CURN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 9000.00
CURN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: 558000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: -1885000.00
CURN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 34473000.00
CURN.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 1285000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 13000.00
CURN.SW income_statement (annual, 2023-12-31) — Gross Profit: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 11921000.00
CURN.SW income_statement (annual, 2023-12-31) — Interest Expense: 17000.00
CURN.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 17000.00
CURN.SW income_statement (annual, 2023-12-31) — Interest Income: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Interest Paid Cfo: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Inventory: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: -179000.00
CURN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6000.00
CURN.SW cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 600000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 133000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 133000.00
CURN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 600000.00
CURN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -6000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Net Debt: 124000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 1000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -49380000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -49380000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -49380000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Net Interest Income: -17000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 600000.00
CURN.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 600000.00
CURN.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -17000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -312000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 8875000.00
CURN.SW income_statement (annual, 2023-12-31) — Normalized Income: -3455296.48
CURN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: -1885000.00
CURN.SW income_statement (annual, 2023-12-31) — Operating Income: -3535000.00
CURN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 290575.00
CURN.SW balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 258000.00
CURN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: 33000.00
CURN.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 170000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 111000.00
CURN.SW income_statement (annual, 2023-12-31) — Other Special Charges: 34473000.00
CURN.SW income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Payables: 41000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Prepaid Assets: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Pretax Income: -50762000.00
CURN.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: -6000.00
CURN.SW cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 12410000.00
CURN.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Research And Development: 716000.00
CURN.SW income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: -13414000.00
CURN.SW cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CURN.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CURN.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 1285000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Share Issued: 292449.00
CURN.SW income_statement (annual, 2023-12-31) — Special Income Charges: -47210000.00
CURN.SW cash_flow (annual, 2023-12-31) — Stock Based Compensation: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: -312000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: -312000.00
CURN.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1285296.48
CURN.SW income_statement (annual, 2023-12-31) — Tax Provision: -1382000.00
CURN.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.03
CURN.SW balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Assets: 120000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: -179000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Debt: 133000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -312000.00
CURN.SW income_statement (annual, 2023-12-31) — Total Expenses: 3535000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 432000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 133000.00
CURN.SW income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -16272000.00
CURN.SW income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1000.00
CURN.SW income_statement (annual, 2023-12-31) — Total Unusual Items: -47210000.00
CURN.SW income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -47210000.00
CURN.SW balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 1874.00
CURN.SW balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
CURN.SW balance_sheet (annual, 2023-12-31) — Working Capital: -179000.00
CURN.SW income_statement (annual, 2023-12-31) — Write Off: 35289000.00
CURN.SW income_statement (annual, 2024-12-31) — +Operating Expense: 4840000.00
CURN.SW income_statement (annual, 2024-12-31) — +Total Revenue: 6896000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 1561000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1561000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1519000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 1519000.00
CURN.SW income_statement (annual, 2024-12-31) — Amortization: 256000.00
CURN.SW cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 256000.00
CURN.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 2910229.00
CURN.SW income_statement (annual, 2024-12-31) — Basic EPS: -1.49
CURN.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 9000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 484000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 484000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3014000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 3014000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3014000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3014000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Cash Financial: 3014000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Cash Financial: 3014000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Inventory: 600000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 514000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 95000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Payable: -68000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 90000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Receivables: -411000.00
CURN.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: 820000.00
CURN.SW cash_flow (annual, 2024-12-31) — Changes In Cash: 3005000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Common Stock: 484000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 484000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 45598000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 45598000.00
CURN.SW cash_flow (annual, 2024-12-31) — Common Stock Issuance: 14000.00
CURN.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 5310000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Current Assets: 5902000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 5902000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Current Liabilities: 3262000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3262000.00
CURN.SW cash_flow (annual, 2024-12-31) — Deferred Tax: -292000.00
CURN.SW cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 256000.00
CURN.SW income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 256000.00
CURN.SW income_statement (annual, 2024-12-31) — Depreciation Income Statement: 0.00
CURN.SW income_statement (annual, 2024-12-31) — Diluted Average Shares: 2910229.00
CURN.SW income_statement (annual, 2024-12-31) — Diluted EPS: -1.49
CURN.SW income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — EBIT: -4593000.00
CURN.SW income_statement (annual, 2024-12-31) — EBITDA: -4337000.00
CURN.SW cash_flow (annual, 2024-12-31) — End Cash Position: 3014000.00
CURN.SW cash_flow (annual, 2024-12-31) — Financing Cash Flow: -183000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Finished Goods: 1324000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1324000.00
CURN.SW cash_flow (annual, 2024-12-31) — Free Cash Flow: -825000.00
CURN.SW cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CURN.SW income_statement (annual, 2024-12-31) — General And Administrative Expense: 236000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 49381000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 49381000.00
CURN.SW income_statement (annual, 2024-12-31) — Gross Profit: 1586000.00
CURN.SW income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CURN.SW income_statement (annual, 2024-12-31) — Interest Expense: 44000.00
CURN.SW income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 44000.00
CURN.SW income_statement (annual, 2024-12-31) — Interest Income: 13000.00
CURN.SW income_statement (annual, 2024-12-31) — Interest Income Non Operating: 13000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Inventory: 1324000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Inventory: 1324000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Invested Capital: 45598000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Invested Capital: 45598000.00
CURN.SW cash_flow (annual, 2024-12-31) — Investing Cash Flow: 4013000.00
CURN.SW cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 14000.00
CURN.SW cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CURN.SW balance_sheet (annual, 2024-12-31) — Long Term Debt: 0.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 0.00
CURN.SW balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CURN.SW cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CURN.SW cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -197000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 4013000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 14000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4345000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -4345000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -4345000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CURN.SW income_statement (annual, 2024-12-31) — Net Interest Income: -31000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -197000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -197000.00
CURN.SW income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -31000.00
CURN.SW cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
CURN.SW balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3783000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -3783000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 250000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 250000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 6676000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 6676000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 3000.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 3000.00
CURN.SW income_statement (annual, 2024-12-31) — Normalized EBITDA: -2922000.00
CURN.SW income_statement (annual, 2024-12-31) — Normalized Income: -3019105.02
CURN.SW cash_flow (annual, 2024-12-31) — Operating Cash Flow: -825000.00
CURN.SW income_statement (annual, 2024-12-31) — Operating Income: -3254000.00
CURN.SW income_statement (annual, 2024-12-31) — Operating Revenue: 6896000.00
CURN.SW balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4838859.00
CURN.SW balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 4838859.00
CURN.SW balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 106000.00